Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Metabolomics | 35 | 2024 | 1675 | 4.640 |
Why?
|
Asthma | 41 | 2024 | 6268 | 3.340 |
Why?
|
Metabolome | 17 | 2024 | 1009 | 2.230 |
Why?
|
Sphingolipids | 5 | 2023 | 177 | 1.130 |
Why?
|
Lymphoma, B-Cell | 4 | 2017 | 945 | 0.770 |
Why?
|
Vitamin D | 14 | 2024 | 3270 | 0.700 |
Why?
|
Prenatal Exposure Delayed Effects | 5 | 2024 | 2538 | 0.670 |
Why?
|
Lysine | 1 | 2024 | 997 | 0.640 |
Why?
|
Hypersensitivity, Immediate | 4 | 2023 | 348 | 0.630 |
Why?
|
Lymphoma, Follicular | 4 | 2015 | 460 | 0.620 |
Why?
|
Vitamins | 7 | 2024 | 1631 | 0.620 |
Why?
|
Chromosomes, Human, Pair 18 | 2 | 2015 | 247 | 0.590 |
Why?
|
Chromosomes, Human, Pair 14 | 2 | 2015 | 286 | 0.580 |
Why?
|
Health | 1 | 2020 | 397 | 0.560 |
Why?
|
Cadmium | 2 | 2018 | 219 | 0.540 |
Why?
|
Vulnerable Populations | 1 | 2022 | 718 | 0.540 |
Why?
|
Hydrocarbons, Chlorinated | 1 | 2017 | 120 | 0.510 |
Why?
|
Lung | 5 | 2024 | 10067 | 0.490 |
Why?
|
Immunoglobulin E | 5 | 2024 | 1495 | 0.490 |
Why?
|
Respiratory Sounds | 8 | 2024 | 702 | 0.470 |
Why?
|
Cholecalciferol | 1 | 2019 | 550 | 0.470 |
Why?
|
Food Hypersensitivity | 4 | 2024 | 734 | 0.430 |
Why?
|
Carcinogens | 2 | 2018 | 452 | 0.430 |
Why?
|
Hypersensitivity | 5 | 2024 | 1169 | 0.420 |
Why?
|
Environmental Pollutants | 3 | 2024 | 1294 | 0.420 |
Why?
|
Translocation, Genetic | 2 | 2015 | 1392 | 0.410 |
Why?
|
Lead | 2 | 2018 | 879 | 0.390 |
Why?
|
Pregnancy | 27 | 2024 | 30237 | 0.380 |
Why?
|
Bacteremia | 1 | 2018 | 987 | 0.370 |
Why?
|
Costa Rica | 4 | 2019 | 187 | 0.370 |
Why?
|
Chromatography, Liquid | 5 | 2023 | 996 | 0.330 |
Why?
|
Interleukin-8 | 2 | 2022 | 702 | 0.330 |
Why?
|
Vital Capacity | 3 | 2021 | 995 | 0.320 |
Why?
|
Humans | 106 | 2024 | 766766 | 0.320 |
Why?
|
Adrenal Cortex Hormones | 4 | 2023 | 1885 | 0.310 |
Why?
|
Child | 32 | 2024 | 80668 | 0.310 |
Why?
|
Eczema | 2 | 2022 | 244 | 0.310 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1691 | 0.310 |
Why?
|
Italy | 5 | 2019 | 856 | 0.310 |
Why?
|
Child, Preschool | 25 | 2024 | 42577 | 0.300 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 6 | 2019 | 1642 | 0.300 |
Why?
|
Sweden | 5 | 2021 | 1382 | 0.300 |
Why?
|
Vitamin D Deficiency | 3 | 2024 | 1349 | 0.290 |
Why?
|
Female | 66 | 2024 | 396520 | 0.280 |
Why?
|
Lipids | 4 | 2023 | 3319 | 0.280 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2014 | 1374 | 0.270 |
Why?
|
Dermatitis, Atopic | 2 | 2024 | 734 | 0.270 |
Why?
|
Bronchodilator Agents | 2 | 2021 | 513 | 0.270 |
Why?
|
Ejaculation | 2 | 2016 | 59 | 0.260 |
Why?
|
Male | 56 | 2024 | 364142 | 0.260 |
Why?
|
Polymorphism, Single Nucleotide | 12 | 2023 | 16044 | 0.250 |
Why?
|
Eicosanoids | 2 | 2024 | 284 | 0.250 |
Why?
|
Forced Expiratory Volume | 2 | 2021 | 1828 | 0.250 |
Why?
|
Membrane Proteins | 3 | 2019 | 7868 | 0.250 |
Why?
|
Premature Birth | 3 | 2022 | 1830 | 0.240 |
Why?
|
Mass Spectrometry | 5 | 2019 | 2198 | 0.240 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2018 | 8621 | 0.230 |
Why?
|
Genetic Predisposition to Disease | 10 | 2023 | 18075 | 0.230 |
Why?
|
Erythrocytes | 1 | 2013 | 2412 | 0.230 |
Why?
|
Case-Control Studies | 12 | 2020 | 22248 | 0.230 |
Why?
|
Macular Degeneration | 2 | 2024 | 1015 | 0.220 |
Why?
|
Genotype | 9 | 2024 | 13036 | 0.220 |
Why?
|
Glucuronosyltransferase | 1 | 2024 | 136 | 0.220 |
Why?
|
Exercise | 1 | 2020 | 5945 | 0.220 |
Why?
|
Prospective Studies | 23 | 2024 | 54871 | 0.210 |
Why?
|
Prostatic Neoplasms | 5 | 2017 | 11094 | 0.210 |
Why?
|
Carnitine | 1 | 2024 | 253 | 0.210 |
Why?
|
Air Pollution | 3 | 2021 | 2391 | 0.210 |
Why?
|
Genome-Wide Association Study | 12 | 2023 | 12806 | 0.210 |
Why?
|
Environmental Exposure | 7 | 2024 | 4554 | 0.210 |
Why?
|
Bilirubin | 1 | 2024 | 439 | 0.200 |
Why?
|
Diabetes, Gestational | 2 | 2022 | 1263 | 0.200 |
Why?
|
C-Reactive Protein | 3 | 2022 | 3853 | 0.200 |
Why?
|
RNA, Ribosomal, 16S | 3 | 2023 | 1044 | 0.190 |
Why?
|
Infant | 15 | 2024 | 36461 | 0.190 |
Why?
|
Inflammation | 4 | 2022 | 10860 | 0.190 |
Why?
|
Biological Therapy | 1 | 2022 | 140 | 0.180 |
Why?
|
Phenols | 1 | 2024 | 526 | 0.180 |
Why?
|
Alkanesulfonic Acids | 1 | 2023 | 198 | 0.180 |
Why?
|
Medically Underserved Area | 1 | 2022 | 268 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2022 | 587 | 0.170 |
Why?
|
Body Mass Index | 5 | 2024 | 13050 | 0.170 |
Why?
|
Epidemiology | 2 | 2019 | 278 | 0.170 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1751 | 0.170 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 325 | 0.160 |
Why?
|
Academies and Institutes | 1 | 2022 | 326 | 0.160 |
Why?
|
Ethanolamines | 1 | 2019 | 152 | 0.160 |
Why?
|
Desensitization, Immunologic | 1 | 2024 | 546 | 0.160 |
Why?
|
BCG Vaccine | 1 | 2022 | 381 | 0.160 |
Why?
|
Cohort Studies | 13 | 2024 | 41710 | 0.160 |
Why?
|
Multiple Myeloma | 2 | 2014 | 5194 | 0.160 |
Why?
|
Alleles | 3 | 2019 | 6895 | 0.160 |
Why?
|
Dietary Supplements | 4 | 2024 | 3429 | 0.160 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.160 |
Why?
|
Epidemiologic Studies | 1 | 2022 | 677 | 0.150 |
Why?
|
Education | 1 | 2021 | 531 | 0.150 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2019 | 418 | 0.150 |
Why?
|
Caffeine | 1 | 2022 | 702 | 0.150 |
Why?
|
Interferon Regulatory Factors | 1 | 2019 | 272 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Eosinophils | 2 | 2023 | 952 | 0.150 |
Why?
|
Benzhydryl Compounds | 1 | 2024 | 944 | 0.150 |
Why?
|
Depression, Postpartum | 1 | 2022 | 354 | 0.150 |
Why?
|
Nitrogen Dioxide | 1 | 2021 | 541 | 0.140 |
Why?
|
Pharmacogenetics | 1 | 2021 | 682 | 0.140 |
Why?
|
Fluorocarbons | 1 | 2023 | 498 | 0.140 |
Why?
|
Puerto Rico | 3 | 2024 | 380 | 0.140 |
Why?
|
Sphingosine | 1 | 2019 | 306 | 0.140 |
Why?
|
Phenotype | 4 | 2023 | 16724 | 0.140 |
Why?
|
Epidemiologic Methods | 2 | 2019 | 1326 | 0.140 |
Why?
|
Lysophospholipids | 1 | 2019 | 336 | 0.140 |
Why?
|
RNA, Bacterial | 1 | 2019 | 393 | 0.140 |
Why?
|
Cell Wall | 1 | 2020 | 419 | 0.140 |
Why?
|
Polychlorinated Biphenyls | 1 | 2019 | 235 | 0.140 |
Why?
|
Candida albicans | 1 | 2020 | 377 | 0.140 |
Why?
|
Air Pollutants | 2 | 2021 | 2931 | 0.130 |
Why?
|
Quantitative Trait Loci | 2 | 2023 | 2136 | 0.130 |
Why?
|
Body Burden | 1 | 2017 | 156 | 0.130 |
Why?
|
Computational Biology | 5 | 2021 | 3564 | 0.130 |
Why?
|
Phosphates | 1 | 2020 | 763 | 0.130 |
Why?
|
Middle Aged | 27 | 2024 | 223257 | 0.130 |
Why?
|
Fungal Proteins | 1 | 2020 | 901 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1280 | 0.130 |
Why?
|
Fish Oils | 1 | 2019 | 483 | 0.120 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 230 | 0.120 |
Why?
|
Breath Tests | 1 | 2016 | 297 | 0.120 |
Why?
|
Infant, Newborn | 8 | 2024 | 26389 | 0.120 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 539 | 0.120 |
Why?
|
Wet Macular Degeneration | 1 | 2017 | 165 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2023 | 872 | 0.120 |
Why?
|
Receptors, Adiponectin | 1 | 2015 | 82 | 0.120 |
Why?
|
Anti-Asthmatic Agents | 1 | 2020 | 572 | 0.120 |
Why?
|
Adult | 25 | 2024 | 223307 | 0.120 |
Why?
|
Cryopreservation | 1 | 2020 | 727 | 0.120 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20144 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 723 | 0.120 |
Why?
|
Adolescent | 11 | 2024 | 88904 | 0.120 |
Why?
|
Genetic Loci | 2 | 2014 | 2630 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 787 | 0.110 |
Why?
|
Linear Models | 1 | 2024 | 5874 | 0.110 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2023 | 1399 | 0.110 |
Why?
|
Risk Factors | 13 | 2024 | 74881 | 0.110 |
Why?
|
Leukemia, Lymphoid | 1 | 2013 | 307 | 0.110 |
Why?
|
Lung Diseases | 2 | 2021 | 1941 | 0.110 |
Why?
|
Administration, Inhalation | 3 | 2022 | 1154 | 0.110 |
Why?
|
B-Lymphocyte Subsets | 1 | 2014 | 240 | 0.110 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2015 | 180 | 0.110 |
Why?
|
Cell Adhesion Molecules | 1 | 2019 | 1612 | 0.110 |
Why?
|
Receptors, IgE | 1 | 2014 | 375 | 0.110 |
Why?
|
NFATC Transcription Factors | 1 | 2015 | 392 | 0.100 |
Why?
|
DNA Methylation | 2 | 2019 | 4427 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2022 | 1238 | 0.100 |
Why?
|
Vascular Diseases | 1 | 2021 | 1161 | 0.100 |
Why?
|
Lipid Metabolism | 2 | 2022 | 1895 | 0.100 |
Why?
|
Chromosomes, Human | 1 | 2014 | 437 | 0.100 |
Why?
|
Influenza, Human | 1 | 2023 | 1543 | 0.100 |
Why?
|
Particulate Matter | 2 | 2021 | 2635 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 880 | 0.100 |
Why?
|
Prenatal Care | 1 | 2019 | 1158 | 0.100 |
Why?
|
Neoplasms | 2 | 2018 | 22350 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1519 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2018 | 6066 | 0.090 |
Why?
|
Aged | 21 | 2024 | 171343 | 0.090 |
Why?
|
Lymphoproliferative Disorders | 1 | 2014 | 527 | 0.090 |
Why?
|
Dietary Fats | 1 | 2018 | 2001 | 0.090 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 695 | 0.090 |
Why?
|
Infant, Premature | 1 | 2020 | 2120 | 0.090 |
Why?
|
Environmental Monitoring | 1 | 2017 | 1468 | 0.090 |
Why?
|
Tryptophan | 2 | 2024 | 484 | 0.090 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8045 | 0.080 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.080 |
Why?
|
Neoplasms, Experimental | 1 | 2014 | 1227 | 0.080 |
Why?
|
Gene Expression | 2 | 2020 | 7585 | 0.080 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12534 | 0.080 |
Why?
|
Tuberculosis | 1 | 2022 | 2011 | 0.080 |
Why?
|
HLA Antigens | 1 | 2014 | 1339 | 0.080 |
Why?
|
Odds Ratio | 2 | 2018 | 9661 | 0.080 |
Why?
|
Genetic Markers | 1 | 2014 | 2603 | 0.070 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1481 | 0.070 |
Why?
|
Bacteria | 1 | 2019 | 2212 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1405 | 0.070 |
Why?
|
MicroRNAs | 1 | 2024 | 3792 | 0.070 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1434 | 0.070 |
Why?
|
Depression | 2 | 2024 | 8228 | 0.070 |
Why?
|
Tandem Mass Spectrometry | 2 | 2023 | 1197 | 0.070 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 3724 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 2 | 2024 | 800 | 0.070 |
Why?
|
Genetic Association Studies | 1 | 2016 | 2746 | 0.070 |
Why?
|
Social Class | 1 | 2015 | 2007 | 0.060 |
Why?
|
Allergens | 2 | 2024 | 1436 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2018 | 3077 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11920 | 0.060 |
Why?
|
Cell Line | 1 | 2019 | 15563 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3459 | 0.060 |
Why?
|
Chromatin | 1 | 2017 | 2977 | 0.060 |
Why?
|
Oxidative Stress | 1 | 2016 | 3139 | 0.060 |
Why?
|
Lymphoma | 1 | 2014 | 1900 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3905 | 0.060 |
Why?
|
Gene Expression Profiling | 2 | 2018 | 9525 | 0.060 |
Why?
|
Portugal | 1 | 2024 | 91 | 0.060 |
Why?
|
Young Adult | 9 | 2022 | 59939 | 0.060 |
Why?
|
Temperature | 2 | 2021 | 2233 | 0.060 |
Why?
|
Risk | 4 | 2019 | 9602 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3702 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3914 | 0.060 |
Why?
|
Feces | 2 | 2022 | 1505 | 0.060 |
Why?
|
Treatment Outcome | 5 | 2024 | 65273 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2971 | 0.050 |
Why?
|
Ontario | 1 | 2024 | 404 | 0.050 |
Why?
|
Sphingomyelins | 1 | 2023 | 104 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2023 | 88 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5199 | 0.050 |
Why?
|
Fatty Acids | 2 | 2023 | 1806 | 0.050 |
Why?
|
Age Factors | 4 | 2021 | 18397 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2019 | 10384 | 0.050 |
Why?
|
Ceramides | 1 | 2023 | 202 | 0.050 |
Why?
|
Immunologic Tests | 1 | 2023 | 101 | 0.050 |
Why?
|
Bile Acids and Salts | 1 | 2024 | 398 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 7057 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2022 | 12430 | 0.050 |
Why?
|
Software Design | 1 | 2022 | 173 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2013 | 3208 | 0.050 |
Why?
|
Prevalence | 2 | 2015 | 15835 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5887 | 0.050 |
Why?
|
Albuterol | 1 | 2021 | 211 | 0.040 |
Why?
|
Immunomodulation | 1 | 2024 | 548 | 0.040 |
Why?
|
Prognosis | 3 | 2016 | 29948 | 0.040 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59550 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15657 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2021 | 297 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39309 | 0.040 |
Why?
|
Fatty Acids, Volatile | 1 | 2019 | 100 | 0.040 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2019 | 191 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2020 | 243 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2021 | 744 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2019 | 239 | 0.040 |
Why?
|
Milk, Human | 1 | 2022 | 490 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2022 | 917 | 0.040 |
Why?
|
Allergy and Immunology | 1 | 2019 | 170 | 0.040 |
Why?
|
Problem Solving | 1 | 2020 | 442 | 0.040 |
Why?
|
Colorado | 1 | 2017 | 167 | 0.040 |
Why?
|
Obesity | 2 | 2017 | 13090 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9404 | 0.040 |
Why?
|
Spirometry | 1 | 2021 | 929 | 0.040 |
Why?
|
Maternal Exposure | 1 | 2024 | 1097 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12245 | 0.030 |
Why?
|
Europe | 2 | 2014 | 3430 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2022 | 996 | 0.030 |
Why?
|
Amino Acids | 1 | 2023 | 1711 | 0.030 |
Why?
|
Benchmarking | 1 | 2023 | 1056 | 0.030 |
Why?
|
Bacteroides fragilis | 1 | 2018 | 250 | 0.030 |
Why?
|
Administration, Oral | 1 | 2024 | 4018 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 1 | 2018 | 453 | 0.030 |
Why?
|
Amines | 1 | 2017 | 280 | 0.030 |
Why?
|
Prostate-Specific Antigen | 2 | 2016 | 2463 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26310 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2325 | 0.030 |
Why?
|
Drug Discovery | 1 | 2023 | 1065 | 0.030 |
Why?
|
Fetus | 1 | 2023 | 1878 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2020 | 712 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2510 | 0.030 |
Why?
|
Natural Killer T-Cells | 1 | 2018 | 319 | 0.030 |
Why?
|
Kallikreins | 1 | 2016 | 219 | 0.030 |
Why?
|
Residence Characteristics | 1 | 2024 | 2116 | 0.030 |
Why?
|
Serpins | 1 | 2016 | 245 | 0.030 |
Why?
|
Eosinophilia | 1 | 2018 | 554 | 0.030 |
Why?
|
Systems Biology | 1 | 2017 | 481 | 0.030 |
Why?
|
DNA Replication | 1 | 2021 | 1426 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2015 | 545 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2021 | 14762 | 0.030 |
Why?
|
Cesarean Section | 1 | 2022 | 1418 | 0.030 |
Why?
|
Meat Products | 1 | 2013 | 97 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2016 | 471 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 630 | 0.030 |
Why?
|
Family | 1 | 2024 | 3209 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 746 | 0.030 |
Why?
|
Cytidine Deaminase | 1 | 2014 | 249 | 0.030 |
Why?
|
Poverty | 1 | 2024 | 2714 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2017 | 811 | 0.030 |
Why?
|
Mothers | 1 | 2023 | 2208 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 313 | 0.020 |
Why?
|
Molecular Epidemiology | 1 | 2014 | 473 | 0.020 |
Why?
|
Nuts | 1 | 2013 | 265 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9346 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2014 | 993 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2018 | 21162 | 0.020 |
Why?
|
Child Development | 1 | 2023 | 2327 | 0.020 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2016 | 1150 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1791 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2013 | 739 | 0.020 |
Why?
|
Dairy Products | 1 | 2013 | 490 | 0.020 |
Why?
|
Social Environment | 1 | 2015 | 1012 | 0.020 |
Why?
|
Cell Survival | 1 | 2020 | 5748 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2015 | 908 | 0.020 |
Why?
|
Internet | 1 | 2022 | 3113 | 0.020 |
Why?
|
Testicular Neoplasms | 1 | 2015 | 805 | 0.020 |
Why?
|
Adiponectin | 1 | 2015 | 1121 | 0.020 |
Why?
|
Incidence | 2 | 2019 | 21525 | 0.020 |
Why?
|
Prostate | 1 | 2017 | 1757 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2978 | 0.020 |
Why?
|
United States | 3 | 2024 | 72951 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1889 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2013 | 1525 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 1996 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2727 | 0.020 |
Why?
|
Fruit | 1 | 2013 | 1166 | 0.020 |
Why?
|
Vegetables | 1 | 2013 | 1199 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2017 | 3681 | 0.020 |
Why?
|
Health Behavior | 1 | 2019 | 2649 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 7119 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4619 | 0.020 |
Why?
|
Overweight | 1 | 2017 | 2446 | 0.020 |
Why?
|
Energy Intake | 1 | 2013 | 2142 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6612 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2902 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3957 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2019 | 7841 | 0.020 |
Why?
|
Nutritional Status | 1 | 2013 | 1621 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 2015 | 2631 | 0.010 |
Why?
|
Biopsy | 1 | 2016 | 6779 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4522 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 2015 | 2561 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2015 | 2184 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9611 | 0.010 |
Why?
|
Logistic Models | 1 | 2017 | 13278 | 0.010 |
Why?
|
Mice | 2 | 2023 | 81889 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2014 | 9547 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12064 | 0.010 |
Why?
|
Algorithms | 1 | 2022 | 14072 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4784 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7871 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12150 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10823 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8731 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15908 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10445 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9513 | 0.010 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4282 | 0.010 |
Why?
|
Smoking | 1 | 2015 | 9077 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13640 | 0.010 |
Why?
|
Animals | 2 | 2023 | 168930 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40149 | 0.010 |
Why?
|
Risk Assessment | 1 | 2013 | 24295 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2015 | 13485 | 0.010 |
Why?
|